APA (7th ed.) Citation

Dopfer-Jablonka, A., Steffens, S., Müller, F., Mikuteit, M., Niewolik, J., Cossmann, A., . . . Heinemann, S. (2022). SARS-CoV-2-specific immune responses in elderly and immunosuppressed participants and patients with hematologic disease or checkpoint inhibition in solid tumors: Study protocol of the prospective, observational CoCo immune study. BMC Infectious Diseases, 22(1), 1. https://doi.org/10.1186/s12879-022-07347-w

Chicago Style (17th ed.) Citation

Dopfer-Jablonka, Alexandra, et al. "SARS-CoV-2-specific Immune Responses in Elderly and Immunosuppressed Participants and Patients with Hematologic Disease or Checkpoint Inhibition in Solid Tumors: Study Protocol of the Prospective, Observational CoCo Immune Study." BMC Infectious Diseases 22, no. 1 (2022): 1. https://doi.org/10.1186/s12879-022-07347-w.

MLA (9th ed.) Citation

Dopfer-Jablonka, Alexandra, et al. "SARS-CoV-2-specific Immune Responses in Elderly and Immunosuppressed Participants and Patients with Hematologic Disease or Checkpoint Inhibition in Solid Tumors: Study Protocol of the Prospective, Observational CoCo Immune Study." BMC Infectious Diseases, vol. 22, no. 1, 2022, p. 1, https://doi.org/10.1186/s12879-022-07347-w.